Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 18, Number 5—May 2012
Dispatch

Origin of Human T-Lymphotropic Virus Type 1 in Rural Côte d’Ivoire

Sébastien Calvignac-Spencer, Edgard V. Adjogoua, Chantal Akoua-Koffi, Claudia Hedemann, Grit Schubert, Heinz Ellerbrok, Siv Aina Jensen Leendertz, Georg Pauli, and Fabian H. LeendertzComments to Author 
Author affiliations: Robert Koch-Institut, Berlin, Germany (S. Calvignac-Spencer, C. Hedemann, G. Schubert, H, Ellerbrok, S.A. Jensen Leendertz, G. Pauli, F. H. Leendertz); Institut Pasteur, Abidjan, Côte d’Ivoire (E.V. Adjogoua, C. Akoua-Koffi)

Main Article

Figure 1

Sampling zone in study of the origin of human T-lymphotropic virus type 1 in rural western Africa, 2006–2007. Taï National Park is indicated in white on the gray background of Côte d’Ivoire. The black rectangle overlapping Taï National Park defines a zone encompassing the 18 villages where study participants resided. Village names and the number of participants are as follows: Daobly (38), Djereoula (31), Djiboulay (40), Gahably (55), Gouléako (37), Goulégui-Béoué (55), Kéibly (90), Pauléoula (2

Figure 1. . . Sampling zone in study of the origin of human T-lymphotropic virus type 1 in rural western Africa, 2006–2007. Taï National Park is indicated in white on the gray background of Côte d’Ivoire. The black rectangle overlapping Taï National Park defines a zone encompassing the 18 villages where study participants resided. Village names and the number of participants are as follows: Daobly (38), Djereoula (31), Djiboulay (40), Gahably (55), Gouléako (37), Goulégui-Béoué (55), Kéibly (90), Pauléoula (20), Ponan (21), Port-Gentil (47), Sakré (75), Sioblooula (35), Taï (26), Tieleoula (40), Zagné (17), Zaïpobly (37), Ziriglo (74).

Main Article

Page created: April 12, 2012
Page updated: April 12, 2012
Page reviewed: April 12, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external